Find therapies in clinical trials near you – page 5

Bioequivalence Study of Dapagliflozin 10 mg Tablets in Healthy Adult Volunteers with Diabetes

Bioequivalence Study of Dapagliflozin 10 mg Tablets in Healthy Adult Volunteers with Diabetes

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Study comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients

Study comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients

Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

Study on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure

Study on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure

Study on Dapagliflozin to Reduce Heart Damage from Chemotherapy in Breast Cancer Patients

Study on Dapagliflozin to Reduce Heart Damage from Chemotherapy in Breast Cancer Patients

Study on the Effect of Dapagliflozin on Blood Magnesium Levels in Patients with Low Magnesium Due to HNF1beta-Associated Kidney Disease

Study on the Effect of Dapagliflozin on Blood Magnesium Levels in Patients with Low Magnesium Due to HNF1beta-Associated Kidney Disease

Study on Dapagliflozin and Balcinrenone for Patients Over 50 with Stage 3 Chronic Kidney Disease

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Study on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease

Study on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease

Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes

Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes